untitled
|
|
- ありさ いざわ
- 6 years ago
- Views:
Transcription
1
2 COLAK Mehmed
3
4
5
6
7
8
9 GH IGF-1
10
11
12
13 GH GH
14
15
16
17
18
19
20
21 Kawashima et al., J Reprod Dev, 52 (2006)
22
23
24
25
26 1 Kawashima et al., J Dairy Sci, 90 (2007)
27 Kawashima et al., J Dairy Sci, 90 (2007)
28 Kawashima et al., J Dairy Sci, 90 (2007)
29
30
31
32
33 P<0.001 vs Kawashima et al., Reproduction, 133 (2007)
34 P<0.05 P< P<0.01 P< Kawashima et al., Reproduction, 133 (2007)
35
36
37 P< vs P< vs Kawashima et al., J Reprod Dev, 53 (2007)
38 P< vs. Kawashima et al., J Reprod Dev, 53 (2007)
39
40 IGF (Insulin-like growth factor), IGF-I IGF-II (Type I II) (1-6)
41
42
43
44 E2
45 Kawashima et al., Reproduction, 133 (2007)
46 P< Kawashima et al., Reproduction, 133 (2007)
47 0.8 n=5 0.8 n= E Kawashima et al., Reproduction, 133 (2007)
48
49
50 Exp.1. ; (1) 1 1 cm 2 mm Aloka SSD cm 11
51 Exp.2. LH ; (1) GnRH 1 cm Pre GnRH GnRH 0.5 h 1 h 2 h 6 h 12 h 24 h 30 h 48 h Acosta et al., Reproduction, 125 (2003)
52 Exp.2. LH ; (1) 1 cm -30 h -24 h -18 h -6 h 0 h LH 6 h 12 h 24 h Acosta et al., Reproduction, 125 (2003)
53 Exp.2. LH ; (1) 42
54 GH
55 LH (E2) FSH LH FSH LH
56 LH LH P4 P4 P4 P4
57
58 FSH LH E2 P4 GH IGF-1?? 5
59 LH >8 mm 1 P4 2 PGF2α 2 42 h 1 LH P4 P4 39
60 PGF2α 42h 3 6
61 VS. (P4 E2) LH GH IGF
62 12 mean SEM F1 F2 F3 F4 12 mean SEM (mm) (mm) Day 1 F1 F2, F3, F4 (P<0.05) Day 1 F1, F2 F3, F4 (P<0.05) 41
63 1 P4 (ng/ml) P4 mean SEM *: P<0.05 **: P<0.01 ***: P<0.001 Between two groups * * * * ** *** E2 (pg/ml) E2 mean SEM *: P<0.05 Between two groups * * * * FSH (ng/ml) FSH mean SEM 2 42
64 LH 1 F1 F1 F2 F3 F2 GH 51
65 mrna expression (x10 4 ) mean SEM a,b: P<0.05 a LH x b y c z mrna expresion (x10 4 ) mean SEM a,b: P<0.05 x,y: P<0.05 a x 0 GH b y b xy
66 1 IGF mean SEM a,b: P<0.05 a 1.5 mean SEM IGF-1 (ng/ml) b b b ab ab ab ab Insulin (ng/ml) Day 2 GH???? 47
67 GH LH IGF-1 2 F1 F2 F1 F2 E2 LH P4 P4 LH 2 P4 E2 LH GH GH IGF
68 : : EIA : P4 GH IGF-1
69 P4 (ng/ml) IGF-1 (ng/ml) Insulin (ng/ml) GH (ng/ml) ab a ab ab ab ab ab b a cd bc ab bcd cd cd d a ab bc ab cd de e de P4 (ng/ml) IGF-1 (ng/ml) Insulin (ng/ml) GH (ng/ml) a b b b b b ab 4 ab 3 abc 2 1 d cd b b a abc bcd Kawashima et al., J Reprod Dev, 53 (2007)
70 E2 LH GH P4?? IGF-1
71 GH LH E2 P4?? LH GH IGF-1 5
72
73 Mehmet ÇOLAK
74
75 Growth hormone GH Insulin? Steroids IGF-1 Insulin-like growth factor-1
76 Control (n=3) P4 (n=4) 2 CIDR BIOPSY SLAUGHTERHOUSE EB inj IM (1 mg) BIOPSY SLAUGHTERHOUSE E2 (n=3) BIOPSY SLAUGHTERHOUSE Serial Blood Collection 15 min, 16 h Daily Blood Collection
77
78 Analysis of Plasma E2, P4, GH, IGF-I and Insulin Hormone analyses were performed by EIA Analysis of GHR, IGFR-I and IR genes Quantitative PCR method using BioRad
79 P4 (ng/ml) *** *** *** *** *** *** *** Mean S.E.M. ***:P< E2 (pg/ml) *** *** DAY
80 Control GH (ng/ml) P4 group E2 group Time (h)
81 (ng/ml/min) a b c Mean S.E.M. a, b, c: P<0.05 (ng/ml) a b a PULSAR program 0 (16 h) b a a Control E2 P4
82 140 Control P4 E2 * Mean S.E.M. *:P< IGF-I (ng/ml) Before After Before After Before After
83 Total GH-R P=0.055 mrna ( 10-7 ) Insulin-R mrna IGF-R1 mrna ( 10-6 ) b a a Control E2 P4 b a a Mean S.E.M. a, b: P<0.05
84 Growth hormone GH E2 IGF-I GHR IGFR-I IR
85 Estradiol+Progesterone Eimeria bovis * * * * * * * * Percentage Feed Intake Day Heath et al, Am J Vet Res (1997)
86 Estrogen+Proegesterone, but not GH *a a *a *a *a Weight Gain (kg) Con EP GH PF C EP\C GH\C * a Heath et al, Am J Vet Res (1997)
87
88 350 Duration (min) * * * *,* * C: control E: endotoxin S: Synovex S (P/E) C/E Saliva S/E Saliva C/E Pant S/E Pant C/E Cough S/E Cough McMahon et al, J. Endocrinol., (1998)
89
90
91
92
93 Growth hormone GH E2 IGF-I GHR
94 Growth hormone GH E2 P4 GHR IGF-I GHIGF-I E2/P4
95 E/P
96 IGF IGF-1 IGF-1
97
98
99
100 Thank you for your attention!!
untitled
Contents 1. 2 2. 3 3. 7 4. 9 5. 14 6. 15 7. 17 8. 19 9. 21 1. growth hormone deficiency : GHD10,00015,000 2 2. 03 1GH T3T4 1 GHRHGHIH -CIGF-1 -CIGF-1 3 1 GHRH GHIH GH TSH LHFSH -C IGF-1 -C IGF-1 T3T4 4
More information1 (1) vs. (2) (2) (a)(c) (a) (b) (c) 31 2 (a) (b) (c) LENCHAR
() 601 1 () 265 OK 36.11.16 20 604 266 601 30.4.5 (1) 91621 3037 (2) 20-12.2 20-13 (3) ex. 2540-64 - LENCHAR 1 (1) vs. (2) (2) 605 50.2.13 41.4.27 10 10 40.3.17 (a)(c) 2 1 10 (a) (b) (c) 31 2 (a) (b) (c)
More information00 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0..0..........0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0... 0...... 0... 0 0 0 0 0 0..0 0... 0 0 0 0 0.0.....0.
More informationMicrosoft Word - 倫理 第40,43,45,46講 テキスト.docx
6 538 ( 552 ) (1) () (2) () ( )( ) 1 vs () (1) (2) () () () ) ()() (3) () ( () 2 () () () ()( ) () (7) (8) () 3 4 5 abc b c 6 a (a) b b ()() 7 c (c) ()() 8 9 10 () 1 ()()() 2 () 3 1 1052 1051 () 1053 11
More information140 120 100 80 60 40 20 0 115 107 102 99 95 97 95 97 98 100 64 72 37 60 50 53 50 36 32 18 H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 1 100 () 80 60 40 20 0 1 19 16 10 11 6 8 9 5 10 35 76 83 73 68 46 44 H11
More information234 50cm
234 50cm () 1 10 2 3 4 1 5 6 2 2 1 7 ( ー ) っ ー っ 8 1 2 10 10 2m 4m 6m 15m 457-2472 585-1154 9 10 2 60 2 100 RC SRC 30 80 500 1 500 500 ) 10 B b A 2 A B 2m 457-2473 585-1154 11 20m a 2m 3 3 1m 75cm 120cm
More information1 23G 2 1 2 3 4 5 6 7 3 a a b c a 4 1 18G 18G 6 6 3 30 34 2 23G 48 23G 1 25 45 5 20 145mm 20 26 0.6 1.000 0.7 1.000mm a b c a 20 b c 24 28 a c d 3 60 70 / a RC 5 15 b 1 3 c 0.5 1 4 6 5 a 5 1 b a b a d
More information取扱説明書 [F-12C]
F-12C 11.7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 a bc b c d d a 15 a b cd e a b c d e 16 17 18 de a b 19 c d 20 a b a b c a d e k l m e b c d f g h i j p q r c d e f g h i j n o s 21 k l m n o p q r s a X
More information合併後の交付税について
(1) (2) 1 0.9 0.7 0.5 0.3 0.1 2 3 (1) (a), 4 (b) (a), (c) (a) 0.9 0.7 0.5 0.3 0.1 (b) (d),(e) (f) (g) (h) (a) (i) (g) (h) (j) (i) 5 (2) 6 (3) (A) (B) (A)+(B) n 1,000 1,000 2,000 n+1 970 970 1,940 3.0%
More information<4D F736F F D B BA908593B98AC782AB82E593E082CC88C091538AC7979D82C98AD682B782E992868AD495F18D908F912E646F63>
12 62 1800 14 3 11 14 4 14 4 30 ... 1... 1... 1... 2... 5... 6... 7... 10... 13... 18... 19 21 22 24 27 28 31 32 33... 34... 35... 37 2 1,650mm () H=2,500W=2,000 460m 750m 500m 42.1m 1.15m () 100% 80%
More informationa n a n ( ) (1) a m a n = a m+n (2) (a m ) n = a mn (3) (ab) n = a n b n (4) a m a n = a m n ( m > n ) m n 4 ( ) 552
3 3.0 a n a n ( ) () a m a n = a m+n () (a m ) n = a mn (3) (ab) n = a n b n (4) a m a n = a m n ( m > n ) m n 4 ( ) 55 3. (n ) a n n a n a n 3 4 = 8 8 3 ( 3) 4 = 8 3 8 ( ) ( ) 3 = 8 8 ( ) 3 n n 4 n n
More information31 gh gw
30 31 gh gw 32 33 1406 1421 640 0 (mm) (mm) MAX1513 MIN349 MIN280 MAX900 gh gw 34 gh gh gw gw gh gh gw gw gh gh gw gw 35 175 176 177 178 179 180 181 195 196 197 198 202 203 2 1 L L L2 L2 L2 L 2 2 1 L L
More informationuntitled
20 2 14 18 10 16 1 1.0mg 0.035mg 2 1 20 2 14 18 10 16 1 1 1 52 1 1 21 7 28 1 29 2 1 20 1 24 18 10 16 1 1 21 7 28 1 29 1 NET 1.0mg EE 0.035mg *NET *NET 1999 2007 *NET *NET 88 NSAIDs GnRH GnRH NSAIDs 20
More informationCHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation
CHEMOTHERAPY CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference
More informationPSCHG000.PS
a b c a ac bc ab bc a b c a c a b bc a b c a ac bc ab bc a b c a ac bc ab bc a b c a ac bc ab bc de df d d d d df d d d d d d d a a b c a b b a b c a b c b a a a a b a b a
More information( )
5 60 2 1 54 ( ) 0.8 2 37 3 180 4 1 9 123654789 1 2 3 4 5 6 7 8 9 5 32 4 9 3 8 2 5 6 0 7 30 36 24 8 8 6 450 3 9 26 5 2 2016 2013-2015 14 10 ABC 24DEF BCADAB BEF A F E B D C 11 4 4 1 5 5 2 6 6 3 12 54 24
More information0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2
24 11 10 24 12 10 30 1 0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2 23% 29% 71% 67% 6% 4% n=1525 n=1137 6% +6% -4% -2% 21% 30% 5% 35% 6% 6% 11% 40% 37% 36 172 166 371 213 226 177 54 382 704 216
More information10 117 5 1 121841 4 15 12 7 27 12 6 31856 8 21 1983-2 - 321899 12 21656 2 45 9 2 131816 4 91812 11 20 1887 461971 11 3 2 161703 11 13 98 3 16201700-3 - 2 35 6 7 8 9 12 13 12 481973 12 2 571982 161703 11
More information(1.2) T D = 0 T = D = 30 kn 1.2 (1.4) 2F W = 0 F = W/2 = 300 kn/2 = 150 kn 1.3 (1.9) R = W 1 + W 2 = = 1100 N. (1.9) W 2 b W 1 a = 0
1 1 1.1 1.) T D = T = D = kn 1. 1.4) F W = F = W/ = kn/ = 15 kn 1. 1.9) R = W 1 + W = 6 + 5 = 11 N. 1.9) W b W 1 a = a = W /W 1 )b = 5/6) = 5 cm 1.4 AB AC P 1, P x, y x, y y x 1.4.) P sin 6 + P 1 sin 45
More information% %
4 8 4 5 414.5 172.1 41.5% 39.8 10% 17 186.4 70.8 4 9 10 11 3 1-1 - 2-2 - - 3 - 10% - 4 - 4060% 5560% 60% 40% 3040 1520 1015 411 7 4 11 610 7080 5060 100 3040 13-5 - 1015 4045 3.04.0 5.06.0 1.52.0 1.01.5
More information10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2
More information180 140 22
21 180 140 22 23 25 50 1 3 350 140 500cm 600 140 24 25 26 27 28 29 30 31 1/12 8.3 1/15 6.7 10 1/8 12.5 1/20 140 90 75 150 60 150 10 30 15 35 2,000 30 32 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 % 100 50 33.3
More information<82D282A982C1746F95F18D908F57967B95B E696E6464>
1 2 (90cm 70cm 2015) 3 (68cm 28cm 30cm 12kg 2015) (77.5 109.5cm 2015) 4 (22cm 50cm 50cm 4.6kg 2015) (45cm 62.5cm 2015) (47.4cm 62.5cm 2014) 5 (28.5cm 23.5cm) (45cm 62cm 2015) (97cm 107cm 2015) 6 7 8 9
More information6 12 10661 93100 227213202 222208197 85kg cm 20 64.521 106856142 2 1 4 3 9767 100 35 cm 7747 208198 90kg 23 5828 10661 93100 cm 227213202 10639 61 64.521 85kg 78kg 70kg 61 100 197204.5 cm 15 61
More information=PAS.. =.. =.... 1% 01% ] = = = = 4 (A/A 2 / /B ) 1 8 2n / n n 64 n 64 n ] ] 4
1 1 1 1.1 1.1.1 3 : 0: + : +0 : : } 40 40 40 = 3 35 35 (38 )? +0+7 30 35-0+0 38 38 +30 5 30 30 +20 16 16 1. [ ] 2. 3. 4. + = etc 1.1.2 Ru 1 2 1.2 1.2.1 =PAS.. =.. =.... 1% 01% ] 1.2.2 = = = = 4 (A/A 2
More information1 1 2 1 3 1 4 2 4.1 AKB............................................... 2 4.2......................................... 6 4.3...........................
24 3 28 : 1 1 2 1 3 1 4 2 4.1 AKB............................................... 2 4.2......................................... 6 4.3............................................. 9 5 9 5.1.........................................
More information取扱説明書 [F-02F]
F-02F 4. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d a b cd 9 e a b c d e 20 2 22 ab a b 23 a b 24 c d e 25 26 o a b c p q r s t u v w d h i j k l e f g d m n a b c d e f g h i j k l m n x 27 o
More information緑化計画作成の手引き 26年4月版
http://www.city.shibuya.tokyo.jp/env/en_eventact/midori_ryokka.html 10 11 12 13 14 15 16 17 18 19 P10 P10 1 P12 2635 Fax (1) 47 03-5388-3554 http://www2.kankyo.metro.tokyo.jp/sizen/sinseisyo/e2/tebiki.htm
More information1. 4cm 16 cm 4cm 20cm 18 cm L λ(x)=ax [kg/m] A x 4cm A 4cm 12 cm h h Y 0 a G 0.38h a b x r(x) x y = 1 h 0.38h G b h X x r(x) 1 S(x) = πr(x) 2 a,b, h,π
. 4cm 6 cm 4cm cm 8 cm λ()=a [kg/m] A 4cm A 4cm cm h h Y a G.38h a b () y = h.38h G b h X () S() = π() a,b, h,π V = ρ M = ρv G = M h S() 3 d a,b, h 4 G = 5 h a b a b = 6 ω() s v m θ() m v () θ() ω() dθ()
More informationEPSON LP-8900ユーザーズガイド
3 4 5 6 7 8 abc ade w p s 9 10 s s 11 p 12 p 13 14 p s 15 p s A B 16 w 17 C p 18 D E F 19 p w G H 20 A B 21 C s p D 22 E s p w 23 w w s 24 p w s 25 w 26 p p 27 w p s 28 w p 29 w p s 30 p s 31 A s B 32
More information日本化学療法学会雑誌第51巻第2号
piperacillin piperacillin PIPC. g Cmax CL PIPC CL CLR CLNR CL PIPC g g Cmax PIPC Key words: piperacillin Piperacillin PIPC PIPC g g PIPC Cmax g g ml g g ml g g ml T T T PIPC g g T Ccr ml min AUCCmax PIPC
More informationuntitled
ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504
More information2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1
More information12331514 20131126 1 2 3 1 2 2 52495 4 1122 1 2 2 2 3 45 1 2 1 3 2 4 Z 8305 1962 8 4 2 1 2 2 35 3 12 1 2 32 4418 4 1 5 323 6 11111 332 5 342 6 1 23 4 2 3 7 3 2 3 25175 19132 8 2 1 1 2 3 4 5 6 7 2 1 2 3
More information> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3
13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >
More information橡'98寺尾班報告書.PDF
(OHSS) interleukin-8 (IL -8) 33 histamine prostaglandin angiotensin 8 IL-8 OHSS 1 IL-8 23 Wistar rat pregnant mare serum gonadotropin 10 unit 48 human chorionic gonadotropin(hcg) 10 unit IL-8 0.2, 2.0,
More information07.報文_及川ら-二校目.indd
8 01 01 4 4 1 5 16 18 6 006 H 18 4 011 H 6 4 1 5 1 5 007 H 19 5 009 1 5 006 007 009 011 9 10 4 000 H 1 4 5 004 H 16 4 004 009 H 1 5 4 4 5 1 4 006 011 1 1 4m 5m 10m 007 1 7 009 009 1 5 10 1 000kg 10a 006
More information% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46
Review on Hair Analysis in the Wakayama Arsenic Case Jun KAWAI Department of Materials Science and Engineering, Kyoto University Sakyo-ku, Kyoto 606-8501, Japan Received 6 December 2014, Revised 29 December
More informationPSCHG000.PS
b c d e f bcd bcf bef cde def b c d e f bcd bcf bef cde def b c d e f bc bf cd de ef b c d e f bc bf cd de ef b c d e f bc bf cd de ef b c d e f bc bf cd de ef b c d e f bcd bcf bef cde def b c d e f bcd
More information10 4 2
1 10 4 2 92 11 3 8 20 10 2 10 20 10 28 3 B 78 111 104 1021 95 10 2 4 10 8 95 18 10 30 11 13 104 20 105 105 105 105 107 5 1 11 26 13301500 6 GH 1 GH 34 7 11 27 9301030 8 4 9 GH 1 23 10 20 60 --------------------------------------------------------------------------------------------------------------------------
More informationcm H.11.3 P.13 2 3-106-
H11.3 H.11.3 P.4-105- cm H.11.3 P.13 2 3-106- 2 H.11.3 P.47 H.11.3 P.27 i vl1 vl2-107- 3 h vl l1 l2 1 2 0 ii H.11.3 P.49 2 iii i 2 vl1 vl2-108- H.11.3 P.50 ii 2 H.11.3 P.52 cm -109- H.11.3 P.44 S S H.11.3
More informationさくらの個別指導 ( さくら教育研究所 ) A 2 2 Q ABC 2 1 BC AB, AC AB, BC AC 1 B BC AB = QR PQ = 1 2 AC AB = PR 3 PQ = 2 BC AC = QR PR = 1
... 0 60 Q,, = QR PQ = = PR PQ = = QR PR = P 0 0 R 5 6 θ r xy r y y r, x r, y x θ x θ θ (sine) (cosine) (tangent) sin θ, cos θ, tan θ. θ sin θ = = 5 cos θ = = 4 5 tan θ = = 4 θ 5 4 sin θ = y r cos θ =
More information04年度LS民法Ⅰ教材改訂版.PDF
?? A AB A B C AB A B A B A B A A B A 98 A B A B A B A B B A A B AB AB A B A BB A B A B A B A B A B A AB A B B A B AB A A C AB A C A A B A B B A B A B B A B A B B A B A B A B A B A B A B A B
More informationA(6, 13) B(1, 1) 65 y C 2 A(2, 1) B( 3, 2) C 66 x + 2y 1 = 0 2 A(1, 1) B(3, 0) P 67 3 A(3, 3) B(1, 2) C(4, 0) (1) ABC G (2) 3 A B C P 6
1 1 1.1 64 A6, 1) B1, 1) 65 C A, 1) B, ) C 66 + 1 = 0 A1, 1) B, 0) P 67 A, ) B1, ) C4, 0) 1) ABC G ) A B C P 64 A 1, 1) B, ) AB AB = 1) + 1) A 1, 1) 1 B, ) 1 65 66 65 C0, k) 66 1 p, p) 1 1 A B AB A 67
More informationuntitled
~ ~ ~ ~ ~ 22 14 10 50cm 2124 15 21 29.5 11, 12 12 20 4040 10 60 60 10 20 20 11 ç ç çç 6070 ç ç çç p. ç çç 4.5cm2.5cm 25 http://www.crdc.gifu-u.ac.jp/edsoftol/water/
More information1. King, V. L., Y. Koketsu, D. Reeves, JL. Xue, G. D. Dial.: Management factors associated with swine breeding herd productivity in the USA. Prey. Vet. Med. 35 : 255-264, 1998. 2. Koketsu, Y., J. E. Pettigrew,
More informationuntitled
CoQ10 CoQ10 CoQ10 CoQ10 CoQ10 (A CoQ10 CoQ10 B CoQ10 CoQ10 C CoQ10 CoQ10 CoQ10 QOL CoQ10 QOL CoQ10 CoQ10 CoQ10 CoQ10 14 還元型 CoQ10 の摂取はインフルエンザウイルス感染に対する予防効果を示す CoQ1050CoQ10 CoQ1080CoQ10 Åberg et al., Arch
More informationDCHP
2. 2 1. 1) 2) 2 Crj:CD(SD)IGS SPF 0 240 1200 6000 ppm 2 F0 10 F0 10 F1 21 F1 3 10 F1 3 10 F2 21 0 240 1200 6000 ppm 1 F0 0 15.88 79.57 401.8 mg/kg/day F0 0 20.80 104.19 510.7 mg/kg/day F1 0 17.84 89.89
More informationuntitled
yoshi@image.med.osaka-u.ac.jp http://www.image.med.osaka-u.ac.jp/member/yoshi/ II Excel, Mathematica Mathematica Osaka Electro-Communication University (2007 Apr) 09849-31503-64015-30704-18799-390 http://www.image.med.osaka-u.ac.jp/member/yoshi/
More information- 1 - 2 ç 21,464 5.1% 7,743 112 11,260 2,349 36.1% 0.5% 52.5% 10.9% 1,039 0.2% 0 1 84 954 0.0% 0.1% 8.1% 91.8% 2,829 0.7% 1,274 1,035 496 24 45.0% 36.6% 17.5% 0.8% 24,886 5.9% 9,661 717 6,350 8,203 38.8%
More information437“ƒ
et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer
More informationuntitled
( ) 200133 3 3 3 3, 7 347 57 10 i ii iii -1- -2- -3- -4- 90011001700mm -5- 4.2 1991 73.5 44.4 7.4 10.5 10.5 7.4 W 3 H 2.25 H 2.25 7.4 51.8 140.6 88.8 268.8m 5,037.9m 2 2mm 16cm916cm 10.5 W 3 H 2.25 62.8
More informationJC1000_5-6.pdf
11 11 10 14 2015 No.1 No.2 A B C D E F A B C D E F G H I J No.3 No.4 A B C D E A B C D E F G H No.5 No.6 A B C D E F G H A B C D E F G H 1 2015 10 14 11 11 No.7 A B C D E F G H I J K L M N O P Q R A B
More information2002.N.x.h.L.......g9/20
1 2 3 4 5 6 1 2 3 4 5 8 9 1 11 11 12 13 k 14 l 16 m 17 n 18 o 19 k 2 l 2 m 21 n 21 o 22 p 23 q 23 r 24 24 25 26 27 28 k 28 l 29 m 29 3 31 34 42 44 1, 8, 6, 4, 2, 1,2 1, 8 6 4 2 1, 8, 6, 4, 2, 1,2 1, 8
More information1. 2 P 2 (x, y) 2 x y (0, 0) R 2 = {(x, y) x, y R} x, y R P = (x, y) O = (0, 0) OP ( ) OP x x, y y ( ) x v = y ( ) x 2 1 v = P = (x, y) y ( x y ) 2 (x
. P (, (0, 0 R {(,, R}, R P (, O (0, 0 OP OP, v v P (, ( (, (, { R, R} v (, (, (,, z 3 w z R 3,, z R z n R n.,..., n R n n w, t w ( z z Ke Words:. A P 3 0 B P 0 a. A P b B P 3. A π/90 B a + b c π/ 3. +
More informationTABLE 1. CHANGES IN HEMODYNAMIC PARAMETERS DURING EXERCISE Figure 1. Hemodynamic changes in right atrial pressure (RAP) bee, and after. Figure 2. Hemo
Yozu Ryohei, Inoue T, Shimomitsu T, Morilnoto T, Sugita Y, Watanabe T, Ishikawa M, Stacy G, Jacobs G, Harasaki H, Nose Y. EXERCISE RESPONSE IN CHRONIC NONPULSATILE (NPBVB) AND PULSATILE TAH ANIMALS. Treadmill
More information200 30 984 1 1854 1713 1000 1008 ED ADL/QOL The European Working Group on Sarcopenia in Older People EWGSOP Asian Working Group for Sarcopenia AWGS D C Zhang, 2006 C Imamura, 2008 ATP Imamura, 2009 Imamura,
More information取扱説明書 [F-08D]
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 a bc d a b c d 17 a b cd e a b c d e 18 19 20 21 22 a c b d 23 24 a b c a b c d e f g a b j k l m n o p q r s t u v h i c d e w 25 d e f g h i j k l m n o p q r s
More information12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
More information日本消化器外科学会雑誌第31巻第7号
Key words: obstructive jaundice, biliary drainage, bile refeeding, hepatectomy Fig. 1 Animal models a: experiment I b: experiment 2 silicon tube Fig. 2 Experimantal design Sham Ope J - l r bile duct Zweeks
More informationEndocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa
Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Department of Obstetrics and Gynecology, Kobe University
More informationBIT -2-
2004.3.31 10 11 12-1- BIT -2- -3-256 258 932 524 585 -4- -5- A B A B AB A B A B C AB A B AB AB AB AB -6- -7- A B -8- -9- -10- mm -11- fax -12- -13- -14- -15- s58.10.1 1255 4.2 30.10-16- -17- -18- -19-6.12.10
More informationEP7000取扱説明書
EP7000 S0109-3012 3 47 811 1213 1419 2021 53 54 5560 61 6263 66 2223 2427 2830 3133 3436 3740 4142 4344 45 46 4750 5152 2 4 5 6 7 1 3 4 5 6 7 8 9 15 16 17 18 13 EP7000 2 10 11 12 13 14 19 20 21 22 23 24
More informationŁ½’¬24flNfix+3mm-‡½‡¹724
571 0.0 31,583 2.0 139,335 8.9 310,727 19.7 1,576,352 100.0 820 0.1 160,247 10.2 38,5012.4 5,7830.4 9,5020.6 41,7592.7 77,8174.9 46,425 2.9 381,410 24.2 1,576,352 100.0 219,332 13.9 132,444 8.4 173,450
More information1 1 3 ABCD ABD AC BD E E BD 1 : 2 (1) AB = AD =, AB AD = (2) AE = AB + (3) A F AD AE 2 = AF = AB + AD AF AE = t AC = t AE AC FC = t = (4) ABD ABCD 1 1
ABCD ABD AC BD E E BD : () AB = AD =, AB AD = () AE = AB + () A F AD AE = AF = AB + AD AF AE = t AC = t AE AC FC = t = (4) ABD ABCD AB + AD AB + 7 9 AD AB + AD AB + 9 7 4 9 AD () AB sin π = AB = ABD AD
More information1990 IMO 1990/1/15 1:00-4:00 1 N N N 1, N 1 N 2, N 2 N 3 N 3 2 x x + 52 = 3 x x , A, B, C 3,, A B, C 2,,,, 7, A, B, C
0 9 (1990 1999 ) 10 (2000 ) 1900 1994 1995 1999 2 SAT ACT 1 1990 IMO 1990/1/15 1:00-4:00 1 N 1990 9 N N 1, N 1 N 2, N 2 N 3 N 3 2 x 2 + 25x + 52 = 3 x 2 + 25x + 80 3 2, 3 0 4 A, B, C 3,, A B, C 2,,,, 7,
More information2 94
32 2008 pp. 93 106 1 Received October 30, 2008 The purpose of this study is to examine the effects of aerobics training class on weight loss for female students in HOKURIKU UNIVERSITY. Seventy four female
More information(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32
More informationHP HP ELF 7 52
58 2017pp. 51103 J-POSTL t KH Coder KH CoderJ-POSTL 2016 4 2018312 51 58 2016 1 5 2017 112 2017 3 56 4 4 11 2 3 HP 2017 2 5 17 5 18 20 3 5 18 5 19 5 20 5 7 HP 4 3 222 25 116 12 2 ELF 7 52 2017 12 2 12
More information<30388DE288E42E696E6464>
Doshisha Journal of Health & Sports Science, 1, 53-60, 2009 53 1 Effects of Step Exercise in Healthy Older People Tomoaki Sakai 1 The purpose of this study was to determine the effect of step exercise
More information1 http://www.manabino-academy.com 1 1 1.1............................................... 1 1.2............................................. 4 1.3............................................. 6 2 8 2.1.............................................
More informationad bc A A A = ad bc ( d ) b c a n A n A n A A det A A ( ) a b A = c d det A = ad bc σ {,,,, n} {,,, } {,,, } {,,, } ( ) σ = σ() = σ() = n sign σ sign(
I n n A AX = I, YA = I () n XY A () X = IX = (YA)X = Y(AX) = YI = Y X Y () XY A A AB AB BA (AB)(B A ) = A(BB )A = AA = I (BA)(A B ) = B(AA )B = BB = I (AB) = B A (BA) = A B A B A = B = 5 5 A B AB BA A
More information無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
More information1,000 700-1 -
23 9 () - 0 - 1,000 700-1 - 2 3 ( 16:0017:00 ( 8:15 8:30 10:3010:50 8:00 8:10 8:10 9:30 11:0011:20 11:3015:30 16:0016:40 16:0016:10 16:50 21:00 4:00 4:006:00 6:00 6:1511:00 11:3012:00 12:3014:30 (1) ()
More information第1部 一般的コメント
(( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12
More information13,825,228 3,707,995 26.8 4.9 25 3 8 9 1 50,000 0.29 1.59 70,000 0.29 1.74 12,500 0.39 1.69 12,500 0.55 10,000 20,000 0.13 1.58 30,000 0.00 1.26 5,000 0.13 1.58 25,000 40,000 0.13 1.58 50,000 0.00 1.26
More informationuntitled
20 7 1 22 7 1 1 2 3 7 8 9 10 11 13 14 15 17 18 19 21 22 - 1 - - 2 - - 3 - - 4 - 50 200 50 200-5 - 50 200 50 200 50 200 - 6 - - 7 - () - 8 - (XY) - 9 - 112-10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 -
More informationuntitled
19 1 19 19 3 8 1 19 1 61 2 479 1965 64 1237 148 1272 58 183 X 1 X 2 12 2 15 A B 5 18 B 29 X 1 12 10 31 A 1 58 Y B 14 1 25 3 31 1 5 5 15 Y B 1 232 Y B 1 4235 14 11 8 5350 2409 X 1 15 10 10 B Y Y 2 X 1 X
More information10 2 2 10 6.5 78 1 65 / 30 / - 2 -
- 1 - 10 2 2 10 6.5 78 1 65 / 30 / - 2 - 3 3 30 8 4 8 6 11 14 45 14 7 8 1-3 - 4 1 () 20 4 9 4 9 3 9 4 PR 4 3-4 - - 5 - PR 15 4 PR 7 8 4 9 10-6 - 9 10 9 10 4 9 10 3 9 10 9 9 9 10 PR 1-7 - PR - 8 - 30 100-9
More informationII (No.2) 2 4,.. (1) (cm) (2) (cm) , (
II (No.1) 1 x 1, x 2,..., x µ = 1 V = 1 k=1 x k (x k µ) 2 k=1 σ = V. V = σ 2 = 1 x 2 k µ 2 k=1 1 µ, V σ. (1) 4, 7, 3, 1, 9, 6 (2) 14, 17, 13, 11, 19, 16 (3) 12, 21, 9, 3, 27, 18 (4) 27.2, 29.3, 29.1, 26.0,
More information... 1... 2... 9... 20... 23 - i - ... 30... 34... 38 - ii - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - 10 (A) (B) (A)(B) (C) (E) (C)(E) 16 3,096 3,700 6,796 975 5,821 17 3,002 4,082 7,084
More information?
240-8501 79-2 Email: nakamoto@ynu.ac.jp 1 3 1.1...................................... 3 1.2?................................. 6 1.3..................................... 8 1.4.......................................
More informationA comparison of abdominal versus vaginal hysterectomy for leiomyoma and adenomyosis Kenji ARAHORI, Hisasi KATAYAMA, Suminori NIOKA Department of Obstetrics and Gnecology, National Maizuru Hospital,Kyoto,
More informationFERRITES March 2014 Mn-Zn EPC
March 214 Mn-Zn EPC (2/29) AV OA (3/29) RoHS EPC EPC PC47 EP Z - 1 2 AL-value Z: PC47 EP 1 PC9 EP3 2 PC95 EP7 EP9 EPC25 EPC25B EPC27 EPC3 C C 3 to +5 3 to +85 RoHSRoHS http://www.tdk.co.jp/rohs/ Cl 9ppm
More informationEPSON VP-1200 取扱説明書
4020178-01 w p s 2 p 3 4 5 6 7 8 p s s s p 9 p A B p C 10 D p E 11 F G H H 12 p G I s 13 p s A D p B 14 C D E 15 F s p G 16 A B p 17 18 s p s 19 p 20 21 22 A B 23 A B C 24 A B 25 26 p s p s 27 28 p s p
More information56cm 1 15 1960 2 8 2 2 1 2008 1992 2 1992 2 3562mm 3773mm 2 1980 1991 2008 2007 2003 5 2 3 2003 2005 2008 2010 2005 2008 2012 2010 2012 4 7 4 5 2 1975 1994 8 2008 NPO 2 2010 3 2013 2016 3 2008 2009 14
More informationエッセー
5.13................................... 3 5.14........................................ 9 5.15.................................. 12 5.16................................ 15 5.17..................... 18 5.18...................................
More information02
Q A Ax Pb Ni Cd Hg Al Q A Q A Q A 1 2 3 2 0 1 2 3 4 5 6 7 0 1 2 3 4 5 6 7 8 0 0 1 2 3 4 1 0 1 2 Q A ng/ml 4500 D H E A 4000 3500 3000 2500 2000 DHEA-S - S 1500 1000 500 0 10 15 20 25 30 35 40 45
More information...J......1803.QX
5 7 9 11 13 15 17 19 21 23 45-1111 48-2314 1 I II 100,000 80,000 60,000 40,000 20,000 0 272,437 80,348 82,207 81,393 82,293 83,696 84,028 82,232 248,983 80,411 4,615 4,757 248,434 248,688 76,708 6,299
More information